Two Sigma Investments’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.67M | Buy |
1,214,699
+324,362
| +36% | +$1.51M | 0.01% | 1125 |
|
|
2025
Q1 | $4.89M | Buy |
+890,337
| New | +$4.89M | 0.01% | 1109 |
|
|
2024
Q3 | – | Sell |
-26,803
| Closed | -$60.3K | – | 3287 |
|
|
2024
Q2 | $60.3K | Sell |
26,803
-103,061
| -79% | -$232K | ﹤0.01% | 2791 |
|
|
2024
Q1 | $287K | Buy |
129,864
+32,515
| +33% | +$71.9K | ﹤0.01% | 2509 |
|
|
2023
Q4 | $229K | Sell |
97,349
-12,577
| -11% | -$29.6K | ﹤0.01% | 2699 |
|
|
2023
Q3 | $204K | Sell |
109,926
-92,286
| -46% | -$172K | ﹤0.01% | 2559 |
|
|
2023
Q2 | $530K | Buy |
+202,212
| New | +$530K | ﹤0.01% | 2230 |
|
|
2022
Q2 | – | Sell |
-150,109
| Closed | -$384K | – | 2925 |
|
|
2022
Q1 | $384K | Buy |
+150,109
| New | +$384K | ﹤0.01% | 2095 |
|
|
2021
Q1 | – | Sell |
-127,094
| Closed | -$625K | – | 2755 |
|
|
2020
Q4 | $625K | Buy |
+127,094
| New | +$625K | ﹤0.01% | 1515 |
|
|
2020
Q3 | – | Sell |
-119,071
| Closed | -$317K | – | 2428 |
|
|
2020
Q2 | $317K | Sell |
119,071
-59,579
| -33% | -$159K | ﹤0.01% | 1599 |
|
|
2020
Q1 | $348K | Buy |
178,650
+153,498
| +610% | +$299K | ﹤0.01% | 1377 |
|
|
2019
Q4 | $177K | Buy |
+25,152
| New | +$177K | ﹤0.01% | 1996 |
|
|
2019
Q2 | – | Sell |
-75,022
| Closed | -$753K | – | 2475 |
|
|
2019
Q1 | $753K | Buy |
+75,022
| New | +$753K | ﹤0.01% | 1522 |
|